Considering challenges for the new Alzheimer's drugs: Clinical, population, and health system...
Recent approvals of amyloid immunotherapy drugs for early Alzheimer's disease (AD) have been highly controversial. In this piece, we consider challenges from the clinical, population health, and...
alz-journals.onlinelibrary.wiley.com